Mohammad Azab

1.8k total citations
49 papers, 1.2k citations indexed

About

Mohammad Azab is a scholar working on Molecular Biology, Hematology and Cancer Research. According to data from OpenAlex, Mohammad Azab has authored 49 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 11 papers in Hematology and 11 papers in Cancer Research. Recurrent topics in Mohammad Azab's work include Epigenetics and DNA Methylation (18 papers), Acute Myeloid Leukemia Research (11 papers) and Histone Deacetylase Inhibitors Research (7 papers). Mohammad Azab is often cited by papers focused on Epigenetics and DNA Methylation (18 papers), Acute Myeloid Leukemia Research (11 papers) and Histone Deacetylase Inhibitors Research (7 papers). Mohammad Azab collaborates with scholars based in United States, Jordan and Italy. Mohammad Azab's co-authors include Karem H. Alzoubi, Omar F. Khabour, Pietro Taverna, Thomas Eissenberg, May F. Sadiq, Gavin Choy, Aram Oganesian, Brian A. Primack, Zaheer‐Ud‐Din Babar and John F. Lyons and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Mohammad Azab

46 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mohammad Azab United States 20 514 210 161 152 141 49 1.2k
Jason Liao United States 22 479 0.9× 194 0.9× 299 1.9× 308 2.0× 66 0.5× 60 1.3k
Jane C. Figueiredo United States 24 414 0.8× 159 0.8× 188 1.2× 557 3.7× 50 0.4× 65 1.6k
Yvonne Lo Hong Kong 17 776 1.5× 223 1.1× 206 1.3× 311 2.0× 13 0.1× 30 2.0k
Yong Guo China 21 721 1.4× 124 0.6× 403 2.5× 90 0.6× 34 0.2× 69 1.5k
Ping Zhou China 24 603 1.2× 279 1.3× 226 1.4× 106 0.7× 8 0.1× 107 1.7k
Maziar Rahmani Canada 20 352 0.7× 182 0.9× 132 0.8× 100 0.7× 31 0.2× 42 2.0k
Alexey Polonikov Russia 26 834 1.6× 471 2.2× 165 1.0× 86 0.6× 47 0.3× 171 2.3k
Alakendu Ghosh India 20 272 0.5× 87 0.4× 54 0.3× 86 0.6× 15 0.1× 88 1.8k
Kinjal Shah Sweden 14 462 0.9× 139 0.7× 104 0.6× 352 2.3× 7 0.0× 33 1.6k

Countries citing papers authored by Mohammad Azab

Since Specialization
Citations

This map shows the geographic impact of Mohammad Azab's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammad Azab with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammad Azab more than expected).

Fields of papers citing papers by Mohammad Azab

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohammad Azab. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammad Azab. The network helps show where Mohammad Azab may publish in the future.

Co-authorship network of co-authors of Mohammad Azab

This figure shows the co-authorship network connecting the top 25 collaborators of Mohammad Azab. A scholar is included among the top collaborators of Mohammad Azab based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohammad Azab. Mohammad Azab is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Chung, Woonbok, Andrew D. Kelly, Patricia Kropf, et al.. (2019). Genomic and epigenomic predictors of response to guadecitabine in relapsed/refractory acute myelogenous leukemia. Clinical Epigenetics. 11(1). 106–106. 20 indexed citations
4.
Savona, Michael R., Olatoyosi Odenike, Philip C. Amrein, et al.. (2019). An oral fixed-dose combination of decitabine and cedazuridine in myelodysplastic syndromes: a multicentre, open-label, dose-escalation, phase 1 study. The Lancet Haematology. 6(4). e194–e203. 92 indexed citations
5.
Matei, Daniela, Sharad Ghamande, Lynda D. Roman, et al.. (2018). A Phase I Clinical Trial of Guadecitabine and Carboplatin in Platinum-Resistant, Recurrent Ovarian Cancer: Clinical, Pharmacokinetic, and Pharmacodynamic Analyses. Clinical Cancer Research. 24(10). 2285–2293. 46 indexed citations
6.
Alzoubi, Karem H., Zuheir Hasan, Omar F. Khabour, et al.. (2018). The effect of high-fat diet on seizure threshold in rats: Role of oxidative stress. Physiology & Behavior. 196. 1–7. 26 indexed citations
7.
Azab, Mohammad, et al.. (2017). Diazepam induced oxidative DNA damage in cultured human lymphocytes. Journal of King Saud University - Science. 30(3). 412–416. 7 indexed citations
8.
Fang, Fang, Joanne M. Munck, Jessica Tang, et al.. (2014). The Novel, Small-Molecule DNA Methylation Inhibitor SGI-110 as an Ovarian Cancer Chemosensitizer. Clinical Cancer Research. 20(24). 6504–6516. 81 indexed citations
9.
Primack, Brian A., Omar F. Khabour, Karem H. Alzoubi, et al.. (2014). The LWDS-10J: Reliability and Validity of the Lebanon Waterpipe Dependence Scale Among University Students in Jordan. Nicotine & Tobacco Research. 16(7). 915–922. 29 indexed citations
10.
Azab, Mohammad, et al.. (2014). In vitro Evaluations of Cytotoxicity and Anti-inflammatory Effects of Peganum harmala Seed Extracts in THP-1-derived Macrophages. European Journal of Medicinal Plants. 5(2). 165–175. 20 indexed citations
11.
Griffiths, Elizabeth A., Gavin Choy, Sanjeev Redkar, et al.. (2013). SGI-110. DNA methyltransferase inhibitor, Oncolytic. Drugs of the Future. 38(8). 535–535. 2 indexed citations
12.
Maio, Michele, Gavin Choy, Alessia Covre, et al.. (2013). Immunomodulatory Activity of SGI-110, a Second Generation Hypomethylating Agent. Annals of Oncology. 24. i7–i7. 1 indexed citations
13.
Mahadevan, Daruka, Geoffrey I. Shapiro, Sandra Kurtin, et al.. (2013). Activity of AT13387, a novel, non-ansamycin inhibitor of heat shock protein 90, against gastrointestinal stromal tumors (GIST).. Journal of Clinical Oncology. 31(4_suppl). 105–105. 6 indexed citations
14.
Griffiths, Elizabeth A., Gavin Choy, Sanjeev Redkar, et al.. (2013). SGI-110. DNA methyltransferase inhibitor, Oncolytic. Drugs of the Future. 38(8). 535–535. 54 indexed citations
15.
Azab, Mohammad, et al.. (2012). Assessment of DNA damage using chromosomal aberrations assay in lymphocytes of waterpipe smokers. International Journal of Occupational Medicine and Environmental Health. 25(3). 218–24. 48 indexed citations
16.
Tibes, Raoul, Gavin Choy, Sanjeev Redkar, et al.. (2012). A phase I, first-in-human dose-escalation study of amuvatinib, a multi-targeted tyrosine kinase inhibitor, in patients with advanced solid tumors. Cancer Chemotherapy and Pharmacology. 71(2). 463–471. 25 indexed citations
17.
Azab, Mohammad, et al.. (2012). Exposure of Pregnant Women to Waterpipe and Cigarette Smoke. Nicotine & Tobacco Research. 15(1). 231–237. 52 indexed citations
18.
Khabour, Omar F., et al.. (2010). Assessment of genotoxicity of waterpipe and cigarette smoking in lymphocytes using the sister‐chromatid exchange assay: A comparative study. Environmental and Molecular Mutagenesis. 52(3). 224–228. 69 indexed citations
19.
Azab, Mohammad, et al.. (2010). Water pipe tobacco smoking among university students in Jordan. Nicotine & Tobacco Research. 12(6). 606–612. 83 indexed citations
20.
Al‐Wahadni, Ahed, et al.. (2006). Learning priorities and attitudes towards computer‐assisted learning of general medical practitioners, general dental practitioners and dental hygienists. International Journal of Dental Hygiene. 4(2). 91–97. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jason Liao Breakdown of academic impact, for papers by Jane C. Figueiredo Breakdown of academic impact, for papers by Yvonne Lo Breakdown of academic impact, for papers by Yong Guo Breakdown of academic impact, for papers by Ping Zhou Breakdown of academic impact, for papers by Maziar Rahmani Breakdown of academic impact, for papers by Alexey Polonikov Breakdown of academic impact, for papers by Alakendu Ghosh Breakdown of academic impact, for papers by Kinjal Shah
Rankless by CCL
2026